BeStock  
股票 › 医疗器械 › IRMD

艾拉迪医疗 IRMD

美股市值排名 #3149医疗器械
$86.31 +$0.77 (+0.90%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $86.31 0.00%
开盘$84.75
昨收$85.54
当日区间$83.31 – $86.49
成交量222.1K
市值$1.10B
市盈率(TTM)46.2
股息率0.89%

基本面

最新报告季度:Q3, ended Sep 2026

营收$24.20M+14.2% YoY
营业利润$8.14M+19.1% YoY
净利润$6.51M+16.7% YoY
摊薄每股收益$0.51+18.6% YoY
自由现金流$6.79M+18.6% YoY
经营现金流$7.00M

营收,近8个季度

$19.4MDec '24$19.5MMar '25$20.4MJun '25$21.2MSep '25$22.7MDec '25$22.0MMar '26$20.5MJun '26$24.2MSep '26

净利润,近8个季度

$5.1MDec '24$4.7MMar '25$5.8MJun '25$5.6MSep '25$6.4MDec '25$5.8MMar '26$5.2MJun '26$6.5MSep '26

各季度摊薄每股收益

0.40Dec '240.37Mar '250.45Jun '250.43Sep '250.50Dec '250.45Mar '260.41Jun '260.51Sep '26

各季度自由现金流

$2.9MDec '24$375.0KMar '25$4.9MJun '25$5.7MSep '25$5.5MDec '25$7.8MMar '26$5.5MJun '26$6.8MSep '26

年度营收

$31.7MFY20$41.8MFY21$53.3MFY22$65.6MFY23$73.2MFY24$83.8MFY25

盈利能力与资产负债表

毛利率75.5%
营业利润率32.3%
净利率26.8%
净资产收益率23.4%
资产收益率20.3%
投入资本回报率23.4%
流动比率8.99
负债/资产比率12.1%
现金及投资$63.29M
净现金(净负债)$63.29M

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $24.20M $20.47M $21.98M $83.81M $22.69M
营业总收入 $24.20M $20.47M $21.98M $83.81M $22.69M
营业成本 $5.75M $5.31M $5.17M $19.49M $5.66M
毛利润 $18.46M $15.16M $16.81M $64.32M $17.03M
营业费用 $10.32M $8.77M $9.58M $38.18M $9.94M
销售及管理费用 $9.44M $8.11M $8.62M $35.20M $9.14M
-销售及营销费用 $4.91M $4.25M $4.05M $17.42M $4.60M
-管理费用 $4.53M $3.87M $4.57M $17.78M $4.54M
研发费用 $875,000.00 $657,000.00 $956,000.00 $2.98M $799,000.00
营业利润 $8.14M $6.39M $7.24M $26.15M $7.09M
其他收入(支出) $529,000.00 $497,000.00 $532,000.00 $205,000.00 -$1.31M
其他非经营性收入(支出) $529,000.00 $497,000.00 $532,000.00 – –
税前利润 $8.67M $6.89M $7.77M $28.36M $7.79M
税费 $2.16M $1.67M $1.95M $5.88M $1.35M
净利润 $6.51M $5.22M $5.82M $22.48M $6.44M
持续经营利润 $6.51M $5.22M $5.82M $22.48M $6.44M
归属母公司净利润 $6.51M $5.22M $5.82M $22.48M $6.44M
归属普通股股东净利润 $6.51M $5.22M $5.82M $22.48M $6.44M
基本每股收益 $0.51 $0.41 $0.46 $1.77 $0.51
摊薄每股收益 $0.51 $0.41 $0.45 $1.75 $0.50
每股股息 $0.20 $0.20 $0.20 $0.68 $0.17
非经营性利息净收入(支出) – – – $2.01M –
非经营性利息收入 – – – $2.01M –
证券出售收益 – – – $2,000.00 –
特殊收益(费用) – – – $203,000.00 –
-固定资产出售收益 – – – $203,000.00 –

资产负债表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
总资产 $121.07M $114.98M $114.39M $108.78M $108.78M
流动资产合计 $92.80M $86.72M $86.42M $81.20M $81.20M
现金及现金等价物与短期投资 $63.29M $59.08M $56.37M $51.16M $51.16M
-现金及现金等价物 $63.29M $59.08M $56.37M $51.16M $51.16M
应收款 $13.67M $13.19M $13.42M $13.67M $13.67M
-应收账款 $13.67M $13.19M $13.42M $13.67M $13.67M
预付资产 $1.10M $792,000.00 $3.13M – –
存货 $13.49M $12.26M $11.88M $11.62M $11.62M
其他流动资产 $1.25M $1.40M $1.63M $4.76M $4.76M
非流动资产合计 $28.27M $28.25M $27.97M $27.57M $27.57M
固定资产净值 $24.08M $24.21M $24.23M $23.86M $23.86M
-固定资产原值 $30.05M $29.88M $29.59M $28.93M $28.93M
-累计折旧 -$5.97M -$5.67M -$5.36M -$5.07M -$5.07M
商誉及其他无形资产 $3.41M $3.44M $3.29M $3.38M $3.38M
-其他无形资产 $3.41M $3.44M $3.29M $3.38M $3.38M
一年以上递延资产 $524,000.00 $363,000.00 $231,000.00 $94,000.00 $94,000.00
其他非流动资产 $258,000.00 $244,000.00 $225,000.00 $239,000.00 $239,000.00
负债合计 $14.62M $13.23M $15.88M $14.16M $14.16M
流动负债合计 $10.32M $9.16M $12.12M $10.18M $10.18M
应付款 $2.97M $2.49M $6.51M $3.63M $3.63M
-应付账款 $2.42M $1.85M $2.18M $1.82M $1.82M
-应付税款合计 $548,000.00 $641,000.00 $4.33M $1.81M $1.81M
一年内应计费用 $3.62M $3.06M $2.07M $3.22M $3.22M
一年内预提费用 $161,000.00 $146,000.00 $144,000.00 $144,000.00 $144,000.00
一年内递延负债 $3.57M $3.47M $3.40M $2.87M $2.87M
非流动负债合计 $4.29M $4.06M $3.76M $3.98M $3.98M
一年以上递延负债 $4.29M $4.06M $3.76M $3.98M $3.98M
股东权益合计 $106.45M $101.75M $98.51M $94.62M $94.62M
股东权益 $106.45M $101.75M $98.51M $94.62M $94.62M
股本 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
-普通股 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
资本公积 $32.35M $31.59M $31.02M $30.39M $30.39M
留存收益 $74.10M $70.15M $67.49M $64.23M $64.23M
其他流动负债 – – – $313,000.00 $313,000.00
长期债务及融资租赁负债 – – – $0.00 $0.00
-长期融资租赁负债 – – – $0.00 $0.00

现金流量表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
经营活动现金流 $7.00M $5.94M $8.29M $24.95M $5.92M
持续经营经营活动现金流净额 $7.00M $5.94M $8.29M $24.95M $5.92M
持续经营净利润 $6.51M $5.22M $5.82M $22.48M $6.44M
折旧、折耗与摊销 $412,000.00 $410,000.00 $455,000.00 $1.17M $381,000.00
递延税款 -$161,000.00 -$132,000.00 -$137,000.00 $2.73M $2.33M
营运资金变动 -$671,000.00 -$344,000.00 $1.42M -$4.35M -$3.95M
-应收款变动 -$593,000.00 $280,000.00 $212,000.00 -$3.03M $191,000.00
-存货变动 -$1.30M -$515,000.00 -$534,000.00 -$1.38M $54,000.00
-预付资产变动 -$158,000.00 $2.56M $7,000.00 -$2.71M -$1.96M
-应付账款及应计费用变动 $1.04M -$3.03M $1.41M $1.33M -$2.34M
-其他流动资产变动 -$14,000.00 -$18,000.00 $13,000.00 -$40,000.00 -$25,000.00
-其他流动负债变动 $0.00 $0.00 $0.00 -$150,000.00 $0.00
-其他营运资金变动 $348,000.00 $380,000.00 $305,000.00 $1.62M $125,000.00
投资活动现金流净额 -$212,000.00 -$443,000.00 -$469,000.00 -$8.42M -$416,000.00
持续经营投资活动现金流净额 -$212,000.00 -$443,000.00 -$469,000.00 -$8.42M -$416,000.00
资本支出 -$82,000.00 -$258,000.00 -$66,000.00 -$656,000.00 -$122,000.00
固定资产购置及出售净额 -$130,000.00 -$185,000.00 -$403,000.00 -$7.77M -$294,000.00
筹资活动现金流 -$2.58M -$2.79M -$2.61M -$17.60M -$10.87M
持续经营筹资活动现金流净额 -$2.58M -$2.79M -$2.61M -$17.60M -$10.87M
已付现金股利 -$2.56M -$2.56M -$2.56M -$15.04M -$8.55M
其他筹资费用净额 -$19,000.00 -$234,000.00 -$50,000.00 -$2.56M -$2.32M
期末现金余额 $63.29M $59.08M $56.37M $51.16M $51.16M
现金净变动 $4.21M $2.71M $5.22M -$1.08M -$5.37M
期初现金余额 $59.08M $56.37M $51.16M $52.23M $56.53M
自由现金流 $6.79M $5.50M $7.82M $16.53M $5.51M
持续经营损益 – – – $37,000.00 $3,000.00
股票期权行使所得 – – – $0.00 $0.00

讨论区

暂无评论——快来第一个聊聊 IRMD。

登录后参与讨论。

Scroll to Top